Modeling predictors and outcomes in myeloproliferative neoplasms and thrombosis
Myeloproliferative neoplasms (MPNs) are characterized by clonal expansion of abnormal hematopoietic stem cells, which...
Most Read
The big Gary Raskob interview
The wheres and whens of the GI bleeding HOKUSAI-VTE Cancer sub-analysis, the new paradigm of cardio-oncology and the...
Coagulopathy and thrombosis in COVID-19 patients: parameters to be checked to assess disease severity
As the clinical evidence keeps on accumulating, we can clearly state that coronavirus disease 2019 (COVID-19) very...
ISTH 2018 – BETHANY SAMUELSON BANNOW
We met with Dr. Bethany Samuelson Bannow during the 64th Annual Scientific and Standardization Committee (SSC) meeting...
PATIENTS’ EXPERIENCE OF LIVING WITH CANCER-ASSOCIATED THROMBOSIS: THE PELICAN PROJECT
The clinical issues and the main consequences of venous thromboembolism (VTE) in patients with cancer are nowadays well...
Recording online for “Updates in Cancer-Associated Thrombosis”
In this webinar, Laurent Bertoletti and Tzu-Fei Wang shared some recent updates on...
A new section with a focus on COVID-19 is available on the ICTHIC magazine website!
In these unprecedented times, we would like to provide specific information on COVID-19 and the related issues on...
UPDATE: 10th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will go virtual....
Thromboprophylaxis in Portuguese Cancer Outpatients: Real-World Insights and Patient Characterization
Venous thromboembolism (VTE) affects up to 20% of cancer patients, presenting a four-to-seven-fold increased risk...
Upcoming Webinar on Current Management in Cancer-associated Thrombosis
Don’t forget to register for the webinar on Current Management in Cancer-associated Thrombosis on Wednesday 20 May...